PHARE BIO INC (EIN 851085804) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

AKHILA KOSARAJU

Phone

6174265900

Tax Period

2024-07-01 to 2025-06-30

PHARE BIO INC, founded in 2020, is a community nonprofit in the Medical Research sector that reported $5.5M in total revenue in fiscal year 2024. Revenue surged 155% from the prior year, signaling strong growth momentum. Expenses of $4.8M left a modest 13% surplus.

Mission

PHARE BIO USES AI/DEEP LEARNING TO DEVELOP NOVEL ANTIBIOTICS TO TACKLE ANTIMICROBIAL RESISTANCE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,386,024

Program Service Revenue $2,993,066

Investment Income $96,982

Other Revenue $0

TOTAL REVENUE $5,476,072

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,475,636

Fundraising Expenses $192,619

Program Expenses $4,047,704

Other Expenses $3,276,393

TOTAL EXPENSES $4,787,029

Year-over-Year Comparison

	2024	2023	Change
Revenue	$5,476,072	$2,148,132	+1.5%
Expenses	$4,787,029	$1,461,003	+2.3%
Net Income	$689,043	$687,129	+0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$607,888

Total Directors

$607,888

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AKHILA KOSARAJU	CEO & PRESIDENT	40.00	Officer Director	$584,833	$23,055	$607,888
WILLIAM FOSTER	CHAIR & TREASURER	1.00	Officer Director	$0	$0	$0
STEVE ELLIS	DIRECTOR	1.00	Director	$0	$0	$0
JAMES COLLINS	DIRECTOR (UNTIL 12/24)	1.00	Director	$0	$0	$0
JOSE-CARLOS GUTTIEREZ-RAMOS	DIRECTOR	1.00	Director	$0	$0	$0
ROBERT PLENGE	DIRECTOR	1.00	Director	$0	$0	$0
SUSAN URAHN	DIRECTOR	1.00	Director	$0	$0	$0
SETH BERKELY	DIRECTOR	1.00	Director	$0	$0	$0
LEANNE MINALL	HEAD OF SCIENCE	40.00	Highest	$158,125	$4,069	$162,194
CLAIRE NISHIOKA ROBINSON	SENIOR DIRECTOR, BUSINESS STRATEGIES	40.00	Highest	$243,333	$12,105	$255,438

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$5,476,072	$4,787,029	$7,089,770	$689,043
2024	$2,148,132	$1,461,003	$2,586,256	$687,129
2023	$2,009,513	$1,249,510	$1,837,494	$760,003
2022	$1,558,823	$1,178,664	$1,009,435	$380,159
2021	$1,057,242	$453,432	$632,271	$603,810

PHARE BIO INC